Jeffrey N. Simmons - 11 Jul 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
PRESIDENT, CEO AND DIRECTOR, Director
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol
ELAN
Transactions as of
11 Jul 2025
Net transactions value
+$2,769
Form type
4
Filing time
15 Jul 2025, 16:11:37 UTC
Previous filing
30 Jun 2025
Next filing
29 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR, Director C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD /s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons 15 Jul 2025 0001479079

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Deferred Stock Units Award $2,769 +186 +1.1% $14.90 17,035 11 Jul 2025 Common Stock 186 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2 Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.